Elsevier, Side Effects of Drugs Annual, Volume 45, January 2023
Medications used in the treatment of Alzheimer's disease include the acetylcholinesterase inhibitors (AChEIs, i.e., donepezil, rivastigmine, and galantamine), the N-methyl-D-aspartate receptor (NDMAR) antagonist, memantine, and the anti-amyloid beta monoclonal antibody, aducanumab.
Elsevier, Diet and Nutrition in Neurological Disorders, Volume , 1 January 2023
This chapter discusses any plausible correlation between malnutrition and the onset of Alzheimer's disease. An overview of Alzheimer's pathophysiology is included to offer an understanding of the various underlying causes leading to its manifestation.
Elsevier,
One Earth, Volume 6, 20 January 2023
Marine aquaculture is predicted to serve an important role in alleviating pressure on fisheries and land-based food production, but aquaculture will not be sustainable without continued innovations in the aquaculture sector. Strong governance and economic conditions play a small but highly significant role in the development of marine aquaculture speices
Elsevier,
Handbook of Lifespan Cognitive Behavioral Therapy: Childhood, Adolescence, Pregnancy, Adulthood, and Aging, Volume , 1 January 2023
This content aligns with Goal 3: Good Health and Wellbeing and Goal 10: Reduced Inequalities by discussing the application of cognitive behavior therapy, an evidence-based psychological approach in adolescents suffering from Asperger syndrome with comorbid depressive disorder.
Radiology Case Reports,
Volume 18, Issue 3,
2023,
Pages 1232-1238
Kallmann syndrome (KS) is a rare genetic disorder that refers to the association between hypogonadotropic hypogonadism and anosmia or hyposmia due to abnormal migration of olfactory axons and gonadotropin-releasing hormone-producing neurons.
